151 related articles for article (PubMed ID: 163856)
21. Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.
Meltzer MS; Tucker RW; Sanford KK; Leonard EJ
J Natl Cancer Inst; 1975 May; 54(5):1177-84. PubMed ID: 1092874
[TBL] [Abstract][Full Text] [Related]
22. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
Schlager SI; Paque RE; Dray S
Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
[TBL] [Abstract][Full Text] [Related]
23. Resistance to tumor growth mediated by Listeria monocytogenes: collaborative and suppressive macrophage-lymphocyte interactions in vitro.
Youdim S; Sharman M
J Immunol; 1976 Nov; 117(5 Pt.2):1860-5. PubMed ID: 825574
[TBL] [Abstract][Full Text] [Related]
24. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
Evans R; Eidlen DM
J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
[TBL] [Abstract][Full Text] [Related]
25. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
26. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
Droller MJ; Remington JS
Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
[TBL] [Abstract][Full Text] [Related]
27. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum.
Basić I; Milas L; Grdina DJ; Withers HR
J Natl Cancer Inst; 1975 Sep; 55(3):589-96. PubMed ID: 1159835
[TBL] [Abstract][Full Text] [Related]
28. Differential cytotoxicity of tumorigenic and nontumorigenic strain-2 guinea pig cells as mediated by syngeneic phytohemagglutinin-stimulated peritoneal exudate cells.
Zwilling BS; Meltzer MS; Evans CH
J Natl Cancer Inst; 1975 Mar; 54(3):743-7. PubMed ID: 1091742
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens.
Meltzer MS; Oppenheim JJ; Littman BH; Leonard EJ; Rapp HJ
J Natl Cancer Inst; 1972 Sep; 49(3):727-34. PubMed ID: 4345967
[No Abstract] [Full Text] [Related]
31. The regulatory role of macrophage factors on rat lymphocyte reactivity.
Brajczewska-Fischer W; Ryzewska A; Gorecka M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):407-10. PubMed ID: 749789
[TBL] [Abstract][Full Text] [Related]
32. In vitro production of the factors effective in the transfer of experimental autoimmune aspermatogenesis.
Pokorná Z; Pekárek J; Svejcar J
Folia Biol (Praha); 1975; 21(2):138-43. PubMed ID: 1100441
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
Wahl SM; Altman LC; Rosenstreich DL
J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
[TBL] [Abstract][Full Text] [Related]
34. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
36. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
Zwilling BS; Leonard EJ; Bast RC; Zbar B
J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
[No Abstract] [Full Text] [Related]
37. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
38. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
Ohanian SH; Borsos T
J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity mediated by soluble macrophage product(s).
Sethi KK; Brandis H
J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
[TBL] [Abstract][Full Text] [Related]
40. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
Fogler WE; Fidler IJ
Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
